Evoke Pharma
EVOK
$0.45
Share price
2.27%
Change (1 day)
-76.68%
Change (1 year)
Categories
Evoke Pharma (EVOK) - Total debt
Total debt on the balance sheet as of December 2023 : $5 M
According to Evoke Pharma 's latest financial reports the company's total debt is $5 M. A company’s total debt is the sum of all current and non-current debts.
Evoke Pharma - Total debt on balance sheet (from 2012 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $5.12 M | 2.33% |
| 2021-12-31 | $5.01 M | -4.45% |
| 2020-12-31 | $5.24 M | 3686.6% |
| 2019-12-31 | $0.13 M | |
| 2018-12-31 | $N/A | |
| 2015-12-31 | $4.37 M | 1.29% |
| 2014-12-31 | $4.32 M | 46.35% |
| 2013-12-31 | $2.95 M | 201.5% |
| 2012-12-31 | $0.97 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 ANI Pharmaceuticals ANIP | $0.28 B | 5,613.38% | 🇺🇸 USA |
 Amphastar Pharmaceuticals AMPH | $0.62 B | 12,372.84% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | $0.33 B | 6,639.72% | 🇺🇸 USA |
 Ironwood Pharmaceuticals
IRWD | $0.71 B | 14,210.76% | 🇺🇸 USA |